Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
RXRX
Market Cap$2.11B
Close$
Share Statistics
| Market cap | $2.11 Billion |
|---|---|
| Enterprise Value | $1.74 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.69 |
| Beta | 0.83 |
| Outstanding Shares | 402,771,972 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.69 |
|---|---|
| PEG | -3.04 |
| Price to Sales | - |
| Price to Book Ratio | 2.8 |
| Enterprise Value to Revenue | 29.09 |
| Enterprise Value to EBIT | -3.06 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Recursion Pharmaceuticals Inc
218 employeesRecursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...